BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21483105)

  • 1. Detection of the TNFSF members BAFF, APRIL, TWEAK and their receptors in normal kidney and renal cell carcinomas.
    Pelekanou V; Notas G; Theodoropoulou K; Kampa M; Takos D; Alexaki VI; Radojicic J; Sofras F; Tsapis A; Stathopoulos EN; Castanas E
    Anal Cell Pathol (Amst); 2011; 34(1-2):49-60. PubMed ID: 21483105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BAFF, APRIL, TWEAK, BCMA, TACI and Fn14 proteins are related to human glioma tumor grade: immunohistochemistry and public microarray data meta-analysis.
    Pelekanou V; Notas G; Kampa M; Tsentelierou E; Stathopoulos EN; Tsapis A; Castanas E
    PLoS One; 2013; 8(12):e83250. PubMed ID: 24376672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stoichiometry of Heteromeric BAFF and APRIL Cytokines Dictates Their Receptor Binding and Signaling Properties.
    Schuepbach-Mallepell S; Das D; Willen L; Vigolo M; Tardivel A; Lebon L; Kowalczyk-Quintas C; Nys J; Smulski C; Zheng TS; Maskos K; Lammens A; Jiang X; Hess H; Tan SL; Schneider P
    J Biol Chem; 2015 Jun; 290(26):16330-42. PubMed ID: 25953898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development.
    Alexaki VI; Notas G; Pelekanou V; Kampa M; Valkanou M; Theodoropoulos P; Stathopoulos EN; Tsapis A; Castanas E
    J Immunol; 2009 Nov; 183(9):5948-56. PubMed ID: 19828625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No evidence that soluble TACI induces signalling via membrane-expressed BAFF and APRIL in myeloid cells.
    Nys J; Smulski CR; Tardivel A; Willen L; Kowalczyk C; Donzé O; Huard B; Hess H; Schneider P
    PLoS One; 2013; 8(4):e61350. PubMed ID: 23620746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The expression of BAFF, APRIL and TWEAK is altered in eczema skin but not in the circulation of atopic and seborrheic eczema patients.
    Chen Y; Lind Enoksson S; Johansson C; Karlsson MA; Lundeberg L; Nilsson G; Scheynius A; Karlsson MC
    PLoS One; 2011; 6(7):e22202. PubMed ID: 21765951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B-cell maturation antigen (BCMA) activation exerts specific proinflammatory effects in normal human keratinocytes and is preferentially expressed in inflammatory skin pathologies.
    Alexaki VI; Pelekanou V; Notas G; Venihaki M; Kampa M; Dessirier V; Sabour-Alaoui S; Stathopoulos EN; Tsapis A; Castanas E
    Endocrinology; 2012 Feb; 153(2):739-49. PubMed ID: 22166983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. APRIL and BAFF proteins increase proliferation of human adipose-derived stem cells through activation of Erk1/2 MAP kinase.
    Zonca M; Mancheño-Corvo P; DelaRosa O; Mañes S; Büscher D; Lombardo E; Planelles L
    Tissue Eng Part A; 2012 Apr; 18(7-8):852-9. PubMed ID: 22059379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BAFF expression correlates with idiopathic inflammatory myopathy disease activity measures and autoantibodies.
    López De Padilla CM; McNallan KT; Crowson CS; Bilgic H; Bram RJ; Hein MS; Ytterberg SR; Amin S; Peterson EJ; Baechler EC; Reed AM
    J Rheumatol; 2013 Mar; 40(3):294-302. PubMed ID: 23322463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor necrosis factor superfamily member (TNFSF) 13 (APRIL) and TNFSF13B (BAFF) downregulate homeostatic immunoglobulin production in the intestines.
    Hashiguchi M; Kashiwakura Y; Kanno Y; Kojima H; Kobata T
    Cell Immunol; 2018 Jan; 323():41-48. PubMed ID: 29100594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease.
    Rickert RC; Jellusova J; Miletic AV
    Immunol Rev; 2011 Nov; 244(1):115-33. PubMed ID: 22017435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selectivity of BAFF/BLyS and APRIL for binding to the TNF family receptors BAFFR/BR3 and BCMA.
    Day ES; Cachero TG; Qian F; Sun Y; Wen D; Pelletier M; Hsu YM; Whitty A
    Biochemistry; 2005 Feb; 44(6):1919-31. PubMed ID: 15697217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BAFF, APRIL, TWE-PRIL: who's who?
    Daridon C; Youinou P; Pers JO
    Autoimmun Rev; 2008 Feb; 7(4):267-71. PubMed ID: 18295728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APRIL is overexpressed in cancer: link with tumor progression.
    Moreaux J; Veyrune JL; De Vos J; Klein B
    BMC Cancer; 2009 Mar; 9():83. PubMed ID: 19291294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling pathways for B cell-activating factor (BAFF) and a proliferation-inducing ligand (APRIL) in human placenta.
    Langat DL; Wheaton DA; Platt JS; Sifers T; Hunt JS
    Am J Pathol; 2008 May; 172(5):1303-11. PubMed ID: 18403603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL.
    Chiu A; Xu W; He B; Dillon SR; Gross JA; Sievers E; Qiao X; Santini P; Hyjek E; Lee JW; Cesarman E; Chadburn A; Knowles DM; Cerutti A
    Blood; 2007 Jan; 109(2):729-39. PubMed ID: 16960154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BAFF and APRIL induce inflammatory activation of THP-1 cells through interaction with their conventional receptors and activation of MAPK and NF-κB.
    Lee SM; Kim EJ; Suk K; Lee WH
    Inflamm Res; 2011 Sep; 60(9):807-15. PubMed ID: 21505913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional expression of TWEAK and the receptor Fn14 in human malignant ovarian tumors: possible implication for ovarian tumor intervention.
    Gu L; Dai L; Cao C; Zhu J; Ding C; Xu HB; Qiu L; Di W
    PLoS One; 2013; 8(3):e57436. PubMed ID: 23469193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BAFF-R and TACI expression on CD3+ T cells: Interplay among BAFF, APRIL and T helper cytokines profile in systemic lupus erythematosus.
    Salazar-Camarena DC; Ortíz-Lazareno P; Marín-Rosales M; Cruz A; Muñoz-Valle F; Tapia-Llanos R; Orozco-Barocio G; Machado-Contreras R; Palafox-Sánchez CA
    Cytokine; 2019 Feb; 114():115-127. PubMed ID: 30467093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of the cytokine receptor TNFRSF13B: A new therapeutic target for triple-negative breast cancer.
    Abo-Elfadl MT; Gamal-Eldeen AM; Ismail MF; Shahin NN
    Cytokine; 2020 Jan; 125():154790. PubMed ID: 31400636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.